Towards a New, Endophenotype-Based Strategy for Pathogenicity Prediction in BRCA1 and BRCA2: In Silico Modeling of the Outcome of HDR/SGE Assays for Missense Variants.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
